Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections

International Journal of Antimicrobial Agents
Fabien LamoureuxChristian Thuillez

Abstract

Voriconazole (VCZ) use is limited by its narrow therapeutic range and significant interpatient variability in exposure. This study aimed to assess (i) the impact of CYP2C19 genotype on VCZ exposure and (ii) the doses required to achieve the therapeutic range in adult patients with invasive fungal infections (IFIs). Therapeutic drug monitoring (TDM) of VCZ, based on trough concentration measurement, and CYP2C19 genotyping were used to guide VCZ dosing in Caucasian patients with IFIs. The two common polymorphisms in Caucasians (CYP2C19*2 and *17), associated with decreased or increased CYP2C19 activity, respectively, were correlated with the daily VCZ dose, pharmacokinetic parameters and concentration-to-dose ratio. In total, 111 trough concentration measurements from 35 genotyped patients were analysed using linear mixed-effect models. The mean VCZ doses required to achieve target concentrations were significantly higher in CYP2C19*17 carriers compared with CYP2C19*1/*1 individuals (P<0.001): 2.57±0.25mg/kg twice daily in CYP2C19*1/*1 patients versus 3.94±0.39mg/kg and 6.75±0.54mg/kg in *1/*17 and *17/*17 patients, respectively. In addition, exposure to VCZ correlated with the CYP2C19*17 variant. Indices of exposure for CYP2C19*...Continue Reading

References

Jan 25, 2006·Clinical Pharmacokinetics·Ann K Daly
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·J SmithD Andes
Sep 11, 2007·The Journal of Antimicrobial Chemotherapy·Mark-David LevinRon H N van Schaik
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andres PascualOscar Marchetti
Mar 26, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Souzan B YanniDhiren R Thakker
Mar 28, 2008·Therapeutic Drug Monitoring·Jeannina Smith, David Andes
Oct 29, 2008·Antimicrobial Agents and Chemotherapy·David AndesOscar Marchetti
Nov 27, 2008·Journal of Clinical Pharmacology·Johanna WeissGerd Mikus
Mar 6, 2009·International Journal of Antimicrobial Agents·Kazuaki MatsumotoKatsushi Yamada
Oct 21, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Souzan B YanniDhiren R Thakker
Dec 3, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael NeelyJill Hoffman
Jun 23, 2010·British Journal of Clinical Pharmacology·Hiroshi YamazakiToshiro Niwa
Jul 28, 2010·Antimicrobial Agents and Chemotherapy·Thomas J WalshIrja Lutsar
Dec 31, 2010·Therapeutic Drug Monitoring·Arwa HassanDavid Czock
Jun 23, 2011·Pharmacogenomics·Gerd MikusJohanna Weiss
Jul 20, 2011·Antimicrobial Agents and Chemotherapy·Peter F TrokeWilliam W Hope
Jul 5, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Wan Beom ParkKyung-Sang Yu
Oct 23, 2012·Frontiers in Genetics·Nuala Ann Helsby, Kathryn Elisa Burns
Feb 21, 2014·The Journal of Antimicrobial Chemotherapy·Michael J DoltonAndrew J McLachlan
Aug 27, 2014·Pharmacogenomics·Andrea CalcagnoStefano Bonora

❮ Previous
Next ❯

Citations

Jun 20, 2016·International Journal of Antimicrobial Agents·Elodie Gautier-VeyretFrançoise Stanke-Labesque
Jun 25, 2016·Journal of Clinical Laboratory Analysis·Santirat PrommasChonlaphat Sukasem
Mar 10, 2017·Pharmacogenetics and Genomics·Julia M BarbarinoRuss B Altman
Jul 1, 2017·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Irina PiatkovMark McLean
Oct 13, 2017·Expert Opinion on Drug Metabolism & Toxicology·Jarrett R Amsden, Paul O Gubbins
Jul 4, 2018·Antimicrobial Agents and Chemotherapy·François DanionOlivier Lortholary
Jan 10, 2018·Clinical Pharmacology and Therapeutics·Naveen MangalStephan Schmidt
Oct 12, 2018·Fundamental & Clinical Pharmacology·Elodie Gautier-VeyretFrançoise Stanke-Labesque
Sep 26, 2019·Expert Opinion on Drug Metabolism & Toxicology·Jamie JohnThomas J Walsh
Apr 7, 2018·The Oncologist·Jai N PatelHoward L McLeod
May 2, 2019·European Journal of Drug Metabolism and Pharmacokinetics·Chaoyang ChenYimin Cui
Aug 9, 2017·Clinical Pharmacology and Therapeutics·Thomas DuflotFabien Lamoureux
May 10, 2017·Open Forum Infectious Diseases·Jeffrey W JansenRyan P Moenster
May 10, 2019·Frontiers in Microbiology·Jingxiang ZhangYuanying Jiang
Apr 8, 2020·Current Fungal Infection Reports·Matthew A Miller, Yee Ming Lee
Mar 18, 2017·Pharmacogenetics and Genomics·Issam S HamadehLarisa H Cavallari
Sep 13, 2017·Annals of Clinical Microbiology and Antimicrobials·Whitley M YiTyree H Kiser
Nov 21, 2020·British Journal of Clinical Pharmacology·Elodie Gautier-VeyretFrançoise Stanke-Labesque
Jun 18, 2021·Respiratory Medicine·D WilmesN Kanaan
Aug 18, 2021·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Feng-Ru HuangLu-Ning Sun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.